GDP
NVO

Great Diamond Partners’s Novo Nordisk NVO Stock Holding History

Great Diamond Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$657K Sell
13,715
-1,112
-7% -$47.8K 0.11% 147
2026
Q1 		$545K Sell
14,827
-28
-0.2% -$1.33K 0.1% 154
2025
Q4 		$756K Sell
14,855
-131
-0.9% -$6.7K 0.15% 130
2025
Q3 		$832K Buy
14,986
+611
+4% +$35.8K 0.16% 123
2025
Q2 		$992K Buy
14,375
+9,010
+168% +$613K 0.21% 109
2025
Q1 		$373K Sell
5,365
-24,739
-82% -$2.04M 0.1% 126
2024
Q4 		$2.59M Sell
30,104
-157
-0.5% -$17K 0.67% 42
2024
Q3 		$3.6M Sell
30,261
-6,279
-17% -$837K 0.92% 28
2024
Q2 		$5.22M Sell
36,540
-96
-0.3% -$12.7K 1.23% 20
2024
Q1 		$4.7M Buy
36,636
+3,792
+12% +$451K 1.08% 22
2023
Q4 		$3.4M Sell
32,844
-732
-2% -$72.4K 0.84% 28
2023
Q3 		$3.05M Buy
33,576
+242
+0.7% +$21.3K 0.83% 32
2023
Q2 		$2.7M Buy
33,334
+13,832
+71% +$1.13M 0.71% 35
2023
Q1 		$1.55M Sell
19,502
-1,524
-7% -$108K 0.45% 56
2022
Q4 		$1.42M Buy
21,026
+784
+4% +$46K 0.44% 57
2022
Q3 		$1.01M Buy
20,242
+10,430
+106% +$559K 0.34% 69
2022
Q2 		$546K Buy
9,812
+618
+7% +$34.3K 0.18% 106
2022
Q1 		$510K Buy
9,194
+3,584
+64% +$184K 0.14% 125
2021
Q4 		$314K Buy
5,610
+218
+4% +$11.8K 0.08% 172
2021
Q3 		$258K Buy
5,392
+582
+12% +$28.1K 0.07% 180
2021
Q2 		$201K Buy
+4,810
New +$186K 0.06% 194
2020
Q2 		– Sell
-12,460
Closed -$375K – 153
2020
Q1 		$375K Sell
12,460
-3,638
-23% -$108K 0.19% 79
2019
Q4 		$465K Buy
+16,098
New +$446K 0.18% 83

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Great Diamond Partners's NVO Position: Q2 2026 in Review

Great Diamond Partners reduced its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, selling an estimated $47.8K and leaving 13,715 shares worth $657K. The position accounts for 0.11% of the portfolio, ranked #147.

Great Diamond Partners first reported a position in NVO in Q4 2019 and has held it in 23 quarters since. The position peaked at $5.22M in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Great Diamond Partners held 13,715 shares of Novo Nordisk worth $657K as of Q2 2026.
  • Great Diamond Partners sold 1,112 Novo Nordisk shares in Q2 2026, an estimated $47.8K.
  • Novo Nordisk made up 0.11% of Great Diamond Partners's portfolio in Q2 2026, its #147 holding.
  • Great Diamond Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 23 quarters since.
  • Great Diamond Partners's Novo Nordisk position peaked at $5.22M in Q2 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.